GW Pharma to Be Acquired for $220 Per Share

GW Pharmaceuticals plc, Creating an Innovative, High-Growth, Global Biopharma Leader Adds high-growth commercial franchise to Neuroscience portfolio with Epidiolex®, the first and only FDA-approved prescription cannabidiol medicine and a potential near-term blockbuster Enhanced product diversification of combined company expected to provide accelerated double-digit revenue growth Anticipated to be accretive in first full year of combined […]